Patents by Inventor Sven Ole Warnaar

Sven Ole Warnaar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
    Patent number: 8828381
    Abstract: A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN). The improved treatment method is characterized in a significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone, resulting in a positive therapeutic response with respect to that observed with single anti-tumor agents alone.
    Type: Grant
    Filed: September 15, 2009
    Date of Patent: September 9, 2014
    Assignee: Wilex AG
    Inventors: Sven Ole Warnaar, Stefan Ullrich
  • CO-ADMINISTRATION OF CG250 AND IL-2 OR IFN-ALPHA FOR TREATING CANCER SUCH AS RENAL CELL CARCINOMAS
    Publication number: 20100008888
    Abstract: A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN). The improved treatment method is characterized in a significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone, resulting in a positive therapeutic response with respect to that observed with single anti-tumor agents alone.
    Type: Application
    Filed: September 15, 2009
    Publication date: January 14, 2010
    Applicant: WILEX AG
    Inventors: Sven Ole Warnaar, Stefan Ullrich
  • Co-administration of cG250 and IL-2 or IFN-? for treating cancer such as renal cell carcinomas
    Patent number: 7632496
    Abstract: A method for enhancing the therapeutic effect of cytokine treatment is disclosed. More specifically the present invention relates to a method for administering to a tumor patient a therapeutic dose of cytokine in combination with antibodies directed against the tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN). The improved treatment method is characterized in a significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone, resulting in a positive therapeutic response with respect to that observed with single anti-tumor agents alone.
    Type: Grant
    Filed: June 23, 2003
    Date of Patent: December 15, 2009
    Assignee: Wilex AG
    Inventors: Sven Ole Warnaar, Stefan Ullrich